Home > Healthcare > Medical Devices > Therapeutic Devices > Nebulizers Market

Nebulizers Market Size

Report ID: GMI3452
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Nebulizers Market Size

Nebulizers Market size was worth more than USD 783 million in 2022 and is estimated to record significant growth at around 9.5% CAGR from 2023 to 2032 driven by the rising prevalence of respiratory diseases globally.

To get key market trends

Download Free Sample

Respiratory ailments have been spreading increasingly owing to the high level of air pollution. Moreover, smoking and occupational exposures cause airway blockage, which leads to COPD. Nebulizers help to ensure that the proper medicine is delivered to the right location in the respiratory system. Research has indicated that using nebulizers can improve outcomes for conditions, including seasonal flu brought on by weather changes, chronic obstructive pulmonary disease (COPD), bronchitis, and even asthma. The National Institute for Health Statistics estimates that 25 million Americans suffer from asthma.

Nebulizers Market Report Attributes
Report Attribute	Details
Base Year:	2022
Nebulizers Market Size in 2022:	USD 783 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	9.5%
2032 Value Projection:	USD 1.9 Billion
Historical Data for:	2018 to 2022
No. of Pages:	310
Tables, Charts & Figures:	577
Segments covered:	Product, Portability, End-use, and Region
Growth Drivers:	Rising prevalence of respiratory diseases such as asthma and COPD globally Increased demand for portable, home-use nebulizers Technological advancements by market players High preference for nebulizers in children with respiratory disease
Pitfalls & Challenges:	Dug loss during nebulization Prolonged drug delivery time

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for nebulizers was valued at over USD 783 million in 2022 and is projected to grow significantly at around 9.5% CAGR between 2023 and 2032 propelled by the rising prevalence of respiratory diseases globally.

Tabletop segment is estimated to surpass a valuation of USD 1 billion by the end of 2032 driven by the availability of reimbursement policies.

North America nebulizers market accounted for more than 38% of the overall industry revenue in 2022 and is expected to grow rapidly through 2032 owing to the high cases of respiratory disorders and chronic diseases in the region.

Sunset Healthcare Solutions, Omron Corporation, PARI Respiratory Equipment, Inc., Allied Healthcare Products, Inc., Koninklijke Philips N.V., VYAIRE MEDICAL, INC., Vectura Group Ltd, Lepu Medical Technology (Beijing) Co. Ltd., and GF Health Products, Inc., are some of the prominent enterprises engaged in the nebulizers industry.